InsidersTradesSigma
Follow the 한스바이오메드 share price and the full insider trade history of the company, a listed equity based in South Korea. Shares are quoted on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 한스바이오메드 has published 6 insider filings. Market capitalisation: €288.8bn. The latest transaction was disclosed on 9 June 2026 (Sale). Among the most active insiders: 네오영. The full history is openly available.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Hans Biomed is a company specializing in the healthcare and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative biomedical solutions.